FdaApplication
NDA 211321
Identifiers
- fda_app_no: NDA211321
Properties
| Property | Value |
|---|---|
| applicant_name | UCB INC |
| application_type | NDA |
| approval_date | 2019-05-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAYZILAM | MIDAZOLAM | 5MG/SPRAY | SPRAY;NASAL |
1 product